dacarbazine and Chemotherapy-Induced Febrile Neutropenia

dacarbazine has been researched along with Chemotherapy-Induced Febrile Neutropenia in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's3 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Advani, RH; Ansell, SM; Bartlett, NL; Chen, R; Connors, JM; Engley, G; Feldman, T; Fenton, K; Forero-Torres, A; Friedberg, JW; Gopal, AK; Gordon, LI; Kuruvilla, J; Manley, TJ; Ramchandren, R; Savage, KJ; Straus, DJ; Younes, A1
Buckstein, R; Chan, KK; Cheung, MC; Graczyk, J; Prica, A1
Chong, G; Doig, R; Grigg, A; Ha, FJ; Hamid, A; Hawkes, EA; Jalali, A; Mckendrick, J; Schwarer, AP1

Trials

1 trial(s) available for dacarbazine and Chemotherapy-Induced Febrile Neutropenia

ArticleYear
Brentuximab Vedotin plus Chemotherapy in North American Subjects with Newly Diagnosed Stage III or IV Hodgkin Lymphoma.
    Clinical cancer research : an official journal of the American Association for Cancer Research, 2019, 03-15, Volume: 25, Issue:6

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Brentuximab Vedotin; Canada; Chemotherapy-Induced Febrile Neutropenia; Dacarbazine; Doxorubicin; Female; Follow-Up Studies; Hodgkin Disease; Humans; Kaplan-Meier Estimate; Lung Injury; Male; Middle Aged; Neoplasm Staging; Peripheral Nervous System Diseases; Progression-Free Survival; United States; Vinblastine

2019

Other Studies

2 other study(ies) available for dacarbazine and Chemotherapy-Induced Febrile Neutropenia

ArticleYear
Granulocyte colony-stimulating factor in secondary prophylaxis for advanced-stage Hodgkin lymphoma treated with ABVD chemotherapy: a cost-effectiveness analysis.
    Leukemia & lymphoma, 2016, Volume: 57, Issue:8

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Canada; Chemotherapy-Induced Febrile Neutropenia; Cohort Studies; Cost-Benefit Analysis; Dacarbazine; Decision Support Systems, Clinical; Doxorubicin; Granulocyte Colony-Stimulating Factor; Hodgkin Disease; Humans; Markov Chains; Neoplasm Staging; Quality-Adjusted Life Years; Secondary Prevention; Treatment Outcome; Vinblastine

2016
Hodgkin lymphoma: an Australian experience of ABVD chemotherapy in the modern era.
    Annals of hematology, 2016, Volume: 95, Issue:5

    Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Australia; Bleomycin; Chemotherapy-Induced Febrile Neutropenia; Combined Modality Therapy; Dacarbazine; Databases, Factual; Disease-Free Survival; Doxorubicin; Female; Hodgkin Disease; Humans; Kaplan-Meier Estimate; Lung Diseases; Male; Medical Records; Middle Aged; Neoplasm Staging; Radiotherapy, Adjuvant; Retrospective Studies; Treatment Outcome; Vinblastine; Young Adult

2016